保守治疗的自发性冠状动脉夹层患者抗血小板治疗:DISCO登记研究
基于DISCO多中心国际登记中199例初始保守治疗的SCAD患者,比较单联(SAPT)与双联(DAPT)抗血小板治疗的1年结局。DAPT组MACE发生率显著高于SAPT组(18.9% vs 6.0%,HR 2.62,95%CI 1.22-5.61,P=0.013),多因素分析显示DAPT与2a型SCAD独立关联于12个月MACE风险升高。
要点
- 保守治疗的SCAD患者中,DAPT组1年MACE发生率显著高于SAPT组。
- DAPT(OR 4.54,95%CI 1.31-14.28,P=0.016)与2a型SCAD独立关联于12个月MACE。
- 多数患者为女性(89%),92%表现为急性冠脉综合征。
核心结论
- 在初始保守治疗的SCAD患者中,与SAPT相比,DAPT独立关联于更高的1年不良心血管事件发生率。
研究设计与样本
- 基于DISCO多中心国际登记,纳入199例初始保守治疗的SCAD患者,按SAPT或DAPT分组比较1年结局。
主要发现
- 12个月随访总体MACE发生率为14.6%。
- DAPT组MACE发生率为18.9%,SAPT组为6.0%(HR 2.62;95%CI 1.22-5.61;P=0.013),主要由早期非致死性MI或非计划PCI过多驱动。
- 多因素回归中,2a型SCAD(OR 3.69;95%CI 1.41-9.61;P=0.007)与DAPT(OR 4.54;95%CI 1.31-14.28;P=0.016)独立关联于12个月MACE风险升高。
- DAPT患者中阿司匹林联合氯吡格雷者占62.9%,联合替格瑞洛者占36.4%。
临床怎么用
- 对初始保守治疗的SCAD患者,处方DAPT需权衡1年MACE风险升高,尤其2a型SCAD患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The role of antiplatelet therapy in patients with spontaneous coronary artery dissection (SCAD) undergoing initial conservative management is still a matter of debate, with theoretical arguments in favour and against its use. The aims of this article are to assess the use of antiplatelet drugs in medically treated SCAD patients and to investigate the relationship between single (SAPT) and dual (DAPT) antiplatelet regimens and 1-year patient outcomes. METHODS AND RESULTS: We investigated the 1-year outcome of patients with SCAD managed with initial conservative treatment included in the DIssezioni Spontanee COronariche (DISCO) multicentre international registry. Patients were divided into two groups according to SAPT or DAPT prescription. Primary endpoint was 12-month incidence of major adverse cardiovascular events (MACE) defined as the composite of all-cause death, non-fatal myocardial infarction (MI), and any unplanned percutaneous coronary intervention (PCI). Out of 314 patients included in the DISCO registry, we investigated 199 patients in whom SCAD was managed conservatively. Most patients were female (89%), presented with acute coronary syndrome (92%) and mean age was 52.3 ± 9.3 years. Sixty-seven (33.7%) were given SAPT whereas 132 (66.3%) with DAPT. Aspirin plus either clopidogrel or ticagrelor were prescribed in 62.9% and 36.4% of DAPT patients, respectively. Overall, a 14.6% MACE rate was observed at 12 months of follow-up. Patients treated with DAPT had a significantly higher MACE rate than those with SAPT [18.9% vs. 6.0% hazard ratios (HR) 2.62; 95% confidence intervals (CI) 1.22-5.61; P = 0.013], driven by an early excess of non-fatal MI or unplanned PCI. At multiple regression analysis, type 2a SCAD (OR: 3.69; 95% CI 1.41-9.61; P = 0.007) and DAPT regimen (OR: 4.54; 95% CI 1.31-14.28; P = 0.016) resulted independently associated with a higher risk of 12-month MACE. CONCLUSIONS: In this European registry, most patients with SCAD undergoing initial conservative management received DAPT. Yet, at 1-year follow-up, DAPT, as compared with SAPT, was independently associated with a higher rate of adverse cardiovascular events (ClinicalTrial.gov id: NCT04415762).
引用
- Cerrato E, Giacobbe F, Quadri G, et al. Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry. Eur Heart J. 2021. PMID: 34338759. doi:10.1093/eurheartj/ehab372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。